Table 2.
Most recent reported dog dosing with praziquantel in each of the six communities sampled.
| Community | No. of dogs sampled | No. of questionnaires administered | No. of dogs reportedly never dosed | No. of dogs with unknown latest dosing | No. of dogs dosed in 6 weeks prior to sampling | No. of dogs dosed >6 weeks to <2 years prior to sampling |
|---|---|---|---|---|---|---|
| Bayenoma | 19 | 18 | 9 (50.0%) | 2 (11.1%) | 2 (11.1%) | 5 (27.8%) |
| Budengjian | 20 | 20 | 1 (5.0%) | 5 (25.0%) | 6 (30.0%) | 8 (40.0%) |
| Changan Kul | 27 | 27 | 4 (14.8%) | 0 (0%) | 12 (44.4%) | 11 (40.7%) |
| Chahete | 20 | 15 | 14 (93.3%) | 1 (6.7%) | 0 (0%) | 0 (0%) |
| Narenhebuke | 21 | 19 | 4 (21.1%) | 6 (31.6%) | 2 (10.5%) | 7 (36.8%) |
| Tiebukenwusan | 19 | 18 | 11 (61.1%) | 2 (11.1%) | 4 (22.2%) | 1 (5.6%) |
| Total | 126 | 117 | 43 (36.8%) | 16 (13.7%) | 26 (22.2%) | 32 (27.4%) |